A review on the use of Ganaxolone in the treatment of Epilepsy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
Brac University
2024
|
| Aiheet: | |
| Linkit: | http://hdl.handle.net/10361/23927 |
| id |
10361-23927 |
|---|---|
| record_format |
dspace |
| spelling |
10361-239272024-09-03T10:13:41Z A review on the use of Ganaxolone in the treatment of Epilepsy Ghosh, Dibbo Protim Chowdhury, Namara Mariam School of Pharmacy, Brac University Ganaxolone CDKL5 deficiency disorder Epilepsy Anti-seizure medication Epilepsy--Treatment. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. Cataloged from the PDF version of thesis. Includes bibliographical references (pages 55-59). Epilepsy currently affects about 50 million people and approximately 10% of the population will have at least one seizure during their lifetime yet very little is known about this condition. This condition can occur as a result of various causes and has multiple proposed pathogenesis. There are multiple types of epilepsy and as of now there is no cure. Even treatment for many types of epilepsy is not available. Ganaxolone is a new anti-seizure medication which has been approved by the USFDA for the treatment for CDD associated epilepsy, it is a first drug in its class. It has shown great promise in the clinical trials as it is effective against treatment resistant epilepsy and exhibits lower side effects and drug interactions. In this review, the clinical trial data of ganaxolone is analyzed and an evaluation of its effectiveness over currently available treatment is provided which can be used to unravel the full potential of this drug in the future. Dibbo Protim Ghosh B. Pharmacy 2024-08-27T09:35:35Z 2024-08-27T09:35:35Z ©2024 2024-03 Thesis ID 20146027 http://hdl.handle.net/10361/23927 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 59 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Ganaxolone CDKL5 deficiency disorder Epilepsy Anti-seizure medication Epilepsy--Treatment. |
| spellingShingle |
Ganaxolone CDKL5 deficiency disorder Epilepsy Anti-seizure medication Epilepsy--Treatment. Ghosh, Dibbo Protim A review on the use of Ganaxolone in the treatment of Epilepsy |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. |
| author2 |
Chowdhury, Namara Mariam |
| author_facet |
Chowdhury, Namara Mariam Ghosh, Dibbo Protim |
| format |
Thesis |
| author |
Ghosh, Dibbo Protim |
| author_sort |
Ghosh, Dibbo Protim |
| title |
A review on the use of Ganaxolone in the treatment of Epilepsy |
| title_short |
A review on the use of Ganaxolone in the treatment of Epilepsy |
| title_full |
A review on the use of Ganaxolone in the treatment of Epilepsy |
| title_fullStr |
A review on the use of Ganaxolone in the treatment of Epilepsy |
| title_full_unstemmed |
A review on the use of Ganaxolone in the treatment of Epilepsy |
| title_sort |
review on the use of ganaxolone in the treatment of epilepsy |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/23927 |
| work_keys_str_mv |
AT ghoshdibboprotim areviewontheuseofganaxoloneinthetreatmentofepilepsy AT ghoshdibboprotim reviewontheuseofganaxoloneinthetreatmentofepilepsy |
| _version_ |
1814308027216429056 |